• Something wrong with this record ?

Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study

S. Koloušková, D. Zemková, J. Bartošová, V. Skalická, Z. Šumník, V. Vávrová, J. Lebl,

. 2011 ; 24 (7-8) : 449-54.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12028048

Cystic fibrosis related diabetes (CFRD) is an insulinopenic condition. We aimed to detect insulinopenia early and to evaluate the impact of low dose insulin on nutritional status and forced expiratory volume in first second (FEV1). Out of 142 cystic fibrosis patients (CFpts) older than 10 years, 28 with abnormal oral glucose tolerance test in spite of normal fasting glycemia were found to have decreased first phase insulin release and started low dose insulin therapy (median age 15.4 years). Sex and age matched CFpts with normal glucose tolerance (NGT) were observed for comparison. Whereas nutritional status improved following 3 years of insulin administration, FEV1 stabilized in insulin-treated insulinopenic subjects (73.8 +/- 4.3% vs. 73.5 +/- 4.4%), but decreased in the parallel group with NGT who remained without insulin treatment (71.1 +/- 3.8% vs. 61.0 +/- 4.0%; p = 0.001). We conclude that low dose insulin improves nutritional status and stabilizes pulmonary functions. Regular estimation of stimulated insulin secretion in CFpts may allow optimizing treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028048
003      
CZ-PrNML
005      
20130213120305.0
007      
ta
008      
120817s2011 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1515/jpem.2011.050 $2 doi
035    __
$a (PubMed)21932580
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Koloušková, Stanislava $u Department of Pediatrics, Second Faculty of Medicine, Charles University in Prague and University Hospital Prague-Motol, V Uvalu 84, CZ-150 06 Praha 5, Czech Republic.
245    10
$a Low-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study / $c S. Koloušková, D. Zemková, J. Bartošová, V. Skalická, Z. Šumník, V. Vávrová, J. Lebl,
520    9_
$a Cystic fibrosis related diabetes (CFRD) is an insulinopenic condition. We aimed to detect insulinopenia early and to evaluate the impact of low dose insulin on nutritional status and forced expiratory volume in first second (FEV1). Out of 142 cystic fibrosis patients (CFpts) older than 10 years, 28 with abnormal oral glucose tolerance test in spite of normal fasting glycemia were found to have decreased first phase insulin release and started low dose insulin therapy (median age 15.4 years). Sex and age matched CFpts with normal glucose tolerance (NGT) were observed for comparison. Whereas nutritional status improved following 3 years of insulin administration, FEV1 stabilized in insulin-treated insulinopenic subjects (73.8 +/- 4.3% vs. 73.5 +/- 4.4%), but decreased in the parallel group with NGT who remained without insulin treatment (71.1 +/- 3.8% vs. 61.0 +/- 4.0%; p = 0.001). We conclude that low dose insulin improves nutritional status and stabilizes pulmonary functions. Regular estimation of stimulated insulin secretion in CFpts may allow optimizing treatment.
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dítě $7 D002648
650    _2
$a kohortové studie $7 D015331
650    _2
$a cystická fibróza $x komplikace $7 D003550
650    _2
$a časná diagnóza $7 D042241
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a porucha glukózové tolerance $x krev $x komplikace $x farmakoterapie $x patofyziologie $7 D018149
650    _2
$a glukózový toleranční test $7 D005951
650    _2
$a glykovaný hemoglobin $x analýza $7 D006442
650    _2
$a lidé $7 D006801
650    _2
$a hypoglykemika $x aplikace a dávkování $x terapeutické užití $7 D007004
650    _2
$a inzulinová rezistence $7 D007333
650    _2
$a NPH inzulin $x aplikace a dávkování $x terapeutické užití $7 D007336
650    _2
$a plíce $x účinky léků $x patofyziologie $7 D008168
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prediabetes $x krev $x komplikace $x farmakoterapie $x patofyziologie $7 D011236
650    _2
$a prospektivní studie $7 D011446
650    _2
$a respirační funkční testy $7 D012129
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zemková, Daniela
700    1_
$a Bartošová, Jana
700    1_
$a Skalická, Veronika
700    1_
$a Šumník, Zdenĕk
700    1_
$a Vávrová, Vĕra
700    1_
$a Lebl, Jan
773    0_
$w MED00180365 $t Journal of pediatric endocrinology & metabolism : JPEM $x 0334-018X $g Roč. 24, č. 7-8 (2011), s. 449-54
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21932580 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20130213120449 $b ABA008
999    __
$a ok $b bmc $g 950090 $s 785394
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 24 $c 7-8 $d 449-54 $i 0334-018X $m Journal of pediatric endocrinology & metabolism $n J Pediatr Endocrinol Metab $x MED00180365
LZP    __
$a Pubmed-20120817/11/04

Find record

Citation metrics

Archiving options